Therapy-related myeloid neoplasms: clinical perspectives

被引:23
作者
Fianchi, Luana [1 ]
Criscuolo, Marianna [1 ]
Fabiani, Emiliano [2 ]
Falconi, Giulia [2 ]
Maraglino, Alessio Maria Edoardo [1 ]
Voso, Maria Teresa [2 ]
Pagano, Livio [1 ]
机构
[1] Fdn Policlin Univ A Gemelli, IRCCS, Dept Radiol Sci Radiotherapy & Hematol, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy
关键词
therapy-related myeloid neoplasm; leukemia; prognosis; secondary leukemia; secondary myelodysplastic syndrome; WORLD-HEALTH-ORGANIZATION; MYELODYSPLASTIC SYNDROMES; CLONAL HEMATOPOIESIS; PROGNOSTIC MODEL; LEUKEMIA; RISK; MUTATIONS; SURVIVAL; EFFICACY; CLASSIFICATION;
D O I
10.2147/OTT.S101333
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Therapy-related myeloid neoplasms (t-MNs) are a complication of cytotoxic treatment for primary tumors and autoimmune diseases. t-MNs result from a complex interaction between individual predisposition and exposition to toxic agents. Some different biological and clinical characteristics can be recognized according to the type of anticancer drug. Compared to de novo myeloid neoplasms, prognosis of t-MN is dismal. Age and karyotype are the most important prognostic factors for t-MN, which should be treated with frontline chemotherapy treatments that are appropriate for patients with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) with similar disease characteristics. Allogeneic stem cell transplantation should be considered particularly for unfavorable karyotypes and younger patients with aggressive disease.
引用
收藏
页码:5909 / 5915
页数:7
相关论文
共 52 条
[1]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[2]   Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation [J].
Bejar, Rafael ;
Stevenson, Kristen E. ;
Caughey, Bennett ;
Lindsley, R. Coleman ;
Mar, Brenton G. ;
Stojanov, Petar ;
Getz, Gad ;
Steensma, David P. ;
Ritz, Jerome ;
Soiffer, Robert ;
Antin, Joseph H. ;
Alyea, Edwin ;
Armand, Philippe ;
Ho, Vincent ;
Koreth, John ;
Neuberg, Donna ;
Cutler, Corey S. ;
Ebert, Benjamin L. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) :2691-+
[3]   Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies [J].
Bertoli, Sarah ;
Sterin, Arthur ;
Tavitian, Suzanne ;
Oberic, Lucie ;
Ysebaert, Loic ;
Bouabdallah, Reda ;
Vergez, Francois ;
Sarry, Audrey ;
Berard, Emilie ;
Huguet, Francoise ;
Laurent, Guy ;
Prebet, Thomas ;
Vey, Norbert ;
Recher, Christian .
ONCOTARGET, 2016, 7 (52) :85937-85947
[4]   Characteristics and Outcomes of Older Patients With Secondary Acute Myeloid Leukemia According to Treatment Approach [J].
Boddu, Prajwal Chaitanya ;
Kantarjian, Hagop M. ;
Ravandi, Farhad ;
Garcia-Manero, Guillermo ;
Verstovsek, Srdan ;
Jabbour, Elias J. ;
Takahashi, Koichi ;
Bhalla, Kapil ;
Konopleva, Marina ;
DiNardo, Courtney D. ;
Ohanian, Maro ;
Pemmaraju, Naveen ;
Jain, Nitin ;
Pierce, Sherry ;
Wierda, William G. ;
Cortes, Jorge E. ;
Kadia, Tapan M. .
CANCER, 2017, 123 (16) :3050-3060
[5]   Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine [J].
Breccia, Massimo ;
Fianchi, Luana ;
Lunghi, Monia ;
Gaidano, Gianluca ;
Levis, Alessandro ;
Finelli, Carlo ;
Santini, Valeria ;
Musto, Pellegrino ;
Mansueto, Giovanna ;
Oliva, Esther N. ;
Leoni, Pietro ;
Spiriti, Maria Antonietta Aloe ;
Hohaus, Stefan ;
Leone, Giuseppe ;
Alimena, Giuliana ;
Voso, Maria Teresa .
LEUKEMIA & LYMPHOMA, 2013, 54 (08) :1786-1787
[6]   Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis [J].
Busque, Lambert ;
Patel, Jay P. ;
Figueroa, Maria E. ;
Vasanthakumar, Aparna ;
Provost, Sylvie ;
Hamilou, Zineb ;
Mollica, Luigina ;
Li, Juan ;
Viale, Agnes ;
Heguy, Adriana ;
Hassimi, Maryam ;
Socci, Nicholas ;
Bhatt, Parva K. ;
Gonen, Mithat ;
Mason, Christopher E. ;
Melnick, Ari ;
Godley, Lucy A. ;
Brennan, Cameron W. ;
Abdel-Wahab, Omar ;
Levine, Ross L. .
NATURE GENETICS, 2012, 44 (11) :1179-1181
[7]   Clonal haemopoiesis in normal elderly women: Implications for the myeloproliferative disorders and myelodysplastic syndromes [J].
Champion, KM ;
Gilbert, JGR ;
Asimakopoulos, FA ;
Hinshelwood, S ;
Green, AR .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (04) :920-926
[8]   Methylenetetrahydrofolate reductase polymorphisms in myelodysplastic syndromes and therapy-related myeloid neoplasms [J].
Criscuolo, Marianna ;
Chiusolo, Patrizia ;
Giammarco, Sabrina ;
Giachelia, Manuela ;
Fianchi, Luana ;
Fabiani, Emiliano ;
Falconi, Giulia ;
Hohaus, Stefan ;
Sica, Simona ;
Leone, Giuseppe ;
Voso, Maria Teresa .
LEUKEMIA & LYMPHOMA, 2014, 55 (12) :2942-2944
[9]   Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].
Doehner, Hartmut ;
Estey, Elihu ;
Grimwade, David ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Larson, Richard A. ;
Levine, Ross L. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel ;
Sierra, Jorge ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wei, Andrew H. ;
Lowenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2017, 129 (04) :424-447
[10]   Clinical and Pathologic Features of Secondary Acute Promyelocytic Leukemia [J].
Duffield, Amy S. ;
Aoki, Joseph ;
Levis, Mark ;
Cowan, Kathleen ;
Gocke, Christopher D. ;
Burns, Kathleen H. ;
Borowitz, Michael J. ;
Vuica-Ross, Milena .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (03) :395-402